FDC, a company in the Pharmaceuticals industry, reported revenue of ₹572 crore and net profit of ₹49 crore for the September 2026 quarter.
FDC (NSE: FDC) closed at ₹377.55 on 20 Nov 2026, down 8.8% over the past year. Its market capitalisation is ₹6,147 crore and it trades at 18.7 times earnings.
FDC (Fairdeal Corporation) Ltd Limited (found in 1936) is among India’s leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialized formulations, and among the world’s foremost manufacturers and marketers of Oral Rehydration Salts (ORS). .
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.